Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 89 publications
Leveraging the unique properties of RNA aptamers to quantify the fraction of receptors occupied by ligands.
Journal: Molecular therapy. Nucleic acids
Published: August 14, 2026
Correction: Veeramani et al. Quantifying PD1 Saturation by PDL1 in Tumor Tissue Using a Novel RNA Aptamer-Based Assay. Int. J. Mol. Sci. 2026, 27, 5469.
Journal: International journal of molecular sciences
Published: July 31, 2026
The Oncology Research Information Exchange Network (ORIEN) - Building a real-world collaborative, patient-driven infrastructure for discovery research and precision oncology.
Journal: Research square
Published: June 12, 2026
The Oncology Research Information Exchange Network (ORIEN) - Building a Real-World Collaborative, Patient-driven Infrastructure for Discovery Research and Precision Oncology.
Journal: Research square
Published: June 12, 2026
Quantifying PD1 Saturation by PDL1 in Tumor Tissue Using a Novel RNA Aptamer-Based Assay.
Journal: International journal of molecular sciences
Published: April 27, 2026
Quantifying PD1 saturation by PDL1 in tumor tissue using a novel RNA aptamer-based assay.
Journal: bioRxiv : the preprint server for biology
Published: April 17, 2026
Intratumoral Virus-Like Particles Containing a TLR9 Agonist Combined with Systemic αPD-1 Activate Tumor-Specific CD8+ T Cells.
Journal: Cancer research communications
Published: March 02, 2026
BDCA2 plays a central role in the binding, internalization and response of plasmacytoid dendritic cells to vidutolimod.
Journal: Frontiers in immunology
Published: December 16, 2025
Multicellular immune ecotypes within solid tumors predict real-world therapeutic benefits with immune checkpoint inhibitors.
Journal: Nature communications
Published: February 04, 2025
In situ treatment with a TLR9 agonist virus-like particle to promote immune responses against oral epithelial dysplasia progression.
Journal: Cancer immunology, immunotherapy : CII
Published: December 17, 2024
Differential Infiltration of Key Immune T-Cell Populations Across Malignancies Varying by Immunogenic Potential and the Likelihood of Response to Immunotherapy.
Journal: Cells
Published: October 22, 2024
Last Updated: 09/26/2026